[
    [
        {
            "time": "",
            "original_text": "甘李药业：第三季度净利4.99亿元 同比增长32%",
            "features": {
                "keywords": [
                    "甘李药业",
                    "第三季度",
                    "净利",
                    "同比增长",
                    "32%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业：第三季度净利4.99亿元 同比增长32%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "甘李药业(603087.SH)：第三季度净利增31.72%至4.99亿元",
            "features": {
                "keywords": [
                    "甘李药业",
                    "603087.SH",
                    "第三季度",
                    "净利",
                    "增长",
                    "31.72%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业(603087.SH)：第三季度净利增31.72%至4.99亿元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "图解甘李药业三季报：第三季度单季净利润同比增长31.72%",
            "features": {
                "keywords": [
                    "甘李药业",
                    "三季报",
                    "第三季度",
                    "单季",
                    "净利润",
                    "同比增长",
                    "31.72%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "图解甘李药业三季报：第三季度单季净利润同比增长31.72%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "甘李药业：2021年第三季度净利润约4.99亿元，同比增长31.72%",
            "features": {
                "keywords": [
                    "甘李药业",
                    "2021年",
                    "第三季度",
                    "净利润",
                    "同比增长",
                    "31.72%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业：2021年第三季度净利润约4.99亿元，同比增长31.72%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "甘李药业：前三季度净利润同比增长26.99%",
            "features": {
                "keywords": [
                    "甘李药业",
                    "前三季度",
                    "净利润",
                    "同比增长",
                    "26.99%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业：前三季度净利润同比增长26.99%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "高瓴资本概念股多数低迷，健帆生物、甘李药业、君实生物大跌并创阶段新低",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "低迷",
                    "健帆生物",
                    "甘李药业",
                    "君实生物",
                    "大跌",
                    "阶段新低"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本概念股多数低迷，健帆生物、甘李药业、君实生物大跌并创阶段新低",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]